{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:59:43Z","timestamp":1764194383677,"version":"build-2065373602"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.clindermatol.2019.07.016","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T19:49:28Z","timestamp":1563392968000},"page":"528-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The color of skin: purple diseases of the skin, nails, and mucosa"],"prefix":"10.1016","volume":"37","author":[{"given":"Alexa B.","family":"Steuer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2019.07.016_bb0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10096-014-2277-6","article-title":"Ecthyma gangrenosum and ecthyma-like lesions: review article","volume":"34","author":"Vaiman","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaad.2018.02.010","article-title":"Lichen planus and lichenoid dermatoses: clinical overview and molecular basis","volume":"79","author":"Tziotzios","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi\u2019s sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-0960.1995.tb00952.x","article-title":"Cutaneous vasculitis and cutaneous vasculopathies","volume":"36","author":"Kelly","year":"1995","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archderm.134.4.491","article-title":"Livedoid vasculopathy: what is it?","volume":"134","author":"Jorizzo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-4632.2004.02213.x","article-title":"Pigmented purpuric dermatoses: an overview","volume":"43","author":"Sardana","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5021\/ad.2015.27.4.404","article-title":"Characteristics and clinical manifestations of pigmented purpuric dermatosis","volume":"27","author":"Kim","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/15569527.2012.702838","article-title":"Sildenafil-induced pigmented purpuric dermatosis","volume":"32","author":"Kocak","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555716870","article-title":"A report of two cases of pigmented purpuric dermatoses treated with PUVA therapy","volume":"71","author":"Wong","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0050","first-page":"1","article-title":"Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review","author":"Plachouri","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-0960.2007.00411.x","article-title":"Narrowband UVB therapy as an effective treatment for Schamberg\u2019s disease","volume":"49","author":"Lasocki","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0060","first-page":"1112","article-title":"Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis","volume":"12","author":"Schober","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rdc.2014.09.006","article-title":"Small vessel vasculitis of the skin","volume":"41","author":"Micheletti","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Sunderkotter","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0190-9622(98)70039-8","article-title":"Cutaneous small-vessel vasculitis","volume":"39","author":"Lotti","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-4632.2005.02898.x","article-title":"Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment","volume":"45","author":"Russell","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2017.9227","article-title":"A Woman With Purple Macules on the Legs","volume":"318","author":"Cohen","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0105","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2340\/00015555-2733","article-title":"Henoch-Schonlein purpura: a literature review","volume":"97","author":"Hetland","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.autrev.2014.01.031","article-title":"The diagnosis and classification of Henoch-Schonlein purpura: an updated review","volume":"13","author":"Yang","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.15403\/jgld.2014.1121.252.csd","article-title":"Immunoglobulin A vasculitis complicated with Clostridium difficile infection: a rare case report and brief review of the literature","volume":"25","author":"Cojocariu","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rdc.2014.09.008","article-title":"Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances","volume":"41","author":"Ghetie","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0190-9622(91)70168-2","article-title":"Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients","volume":"25","author":"Cohen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature","volume":"11","author":"Ferri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2014.01.028","article-title":"Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener\u2019s granulomatosis)","volume":"48-49","author":"Lutalo","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11926-017-0641-0","article-title":"ANCA-associated vasculitis pathogenesis: a commentary","volume":"19","author":"Gapud","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11926-012-0286-y","article-title":"Pathogenesis of ANCA-associated vasculitis","volume":"14","author":"Cartin-Ceba","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0190-9622(94)70224-1","article-title":"Specks U, el-Azhary RA, Su WP. Cutaneous Wegener\u2019s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients","volume":"31","author":"Daoud","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1600-0560.2006.00699.x","article-title":"Cutaneous manifestations of Wegener\u2019s granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status","volume":"34","author":"Comfere","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.det.2015.03.012","article-title":"Granulomatous vasculitis","volume":"33","author":"Sharma","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00325481.2018.1503920","article-title":"Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features","volume":"130","author":"Grygiel-Gorniak","year":"2018","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management","volume":"26","author":"Mahr","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0210","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jaip.2018.07.001","article-title":"Eosinophilic granulomatosis with polyangiitis: clinical pathology conference and review","volume":"6","author":"Wu","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg-Strauss syndrome","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-018-0736-2","article-title":"Eosinophilic granulomatosis with polyangiitis: newer therapies","volume":"20","author":"Navarro-Mendoza","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e32834d85ce","article-title":"Churg-Strauss syndrome: update on pathophysiology and treatment","volume":"24","author":"Vaglio","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0034","article-title":"Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview","volume":"86","author":"Kawakami","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1673387","article-title":"Microscopic polyangiitis: new insights into pathogenesis, clinical features and therapy","volume":"39","author":"Karras","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0245","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0250","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2008.08725.x","article-title":"Frances C; French Vasculitis Study Group. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis","volume":"159","author":"Kluger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0255","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaad.2007.05.012","article-title":"Clinical and histopathologic features of 8 patients with microscopic polyangiitis including two with a slowly progressive clinical course","volume":"57","author":"Kawakami","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0260","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12016-017-8612-9","article-title":"Cutaneous manifestations of medium- and large-vessel vasculitis","volume":"53","author":"Chasset","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0265","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.21186","article-title":"Case report and review of minocycline-induced cutaneous polyarteritis nodosa","volume":"53","author":"Culver","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0270","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2310\/7750.2014.13165","article-title":"Cutaneous polyarteritis nodosa sine nodosa","volume":"18","author":"Merman","year":"2014","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0275","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-4632.2010.04522.x","article-title":"Cutaneous polyarteritis nodosa: a comprehensive review","volume":"49","author":"Morgan","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1346-8138.1989.tb01582.x","article-title":"Cutaneous polyarteritis nodosa: a clinical and histopathological study of 20 cases","volume":"16","author":"Chen","year":"1989","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3400\/avd.ra.12.00061","article-title":"Cutaneous polyarteritis nodosa: an update","volume":"5","author":"Furukawa","year":"2012","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0290","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5021\/ad.2014.26.1.96","article-title":"Warfarin-induced skin necrosis","volume":"26","author":"Kakagia","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0295","first-page":"3121469","article-title":"Dabigatran in the treatment of warfarin-induced skin necrosis: a new hope","volume":"2016","author":"Bakoyiannis","year":"2016","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0300","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2168.2000.01352.x","article-title":"Warfarin induced skin necrosis","volume":"87","author":"Chan","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaad.2008.12.039","article-title":"Warfarin-induced skin necrosis","volume":"61","author":"Nazarian","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0310","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2015.08.071","article-title":"Coagulation disorders and their cutaneous presentations: diagnostic work-up and treatment","volume":"74","author":"Dabiri","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0315","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0320","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0032-1306432","article-title":"Heparin-induced thrombocytopenia: an update","volume":"38","author":"Prechel","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0325","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pathol.2017.02.005","article-title":"Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update","volume":"49","author":"Favaloro","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0330","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(12)60409-7","article-title":"Heparin-induced skin lesions","volume":"380","author":"Schindewolf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1525-1470.1998.1998015169.x","article-title":"Acute infectious purpura fulminans: pathogenesis and medical management","volume":"15","author":"Darmstadt","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0340","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/bja\/86.4.581","article-title":"Review of management of purpura fulminans and two case reports","volume":"86","author":"Nolan","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0345","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2007-1002683","article-title":"Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies","volume":"16","author":"Marlar","year":"1990","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0350","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/adc.2010.199919","article-title":"Purpura fulminans: recognition, diagnosis and management","volume":"96","author":"Chalmers","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0355","article-title":"Pathogenesis of meningococcal purpura fulminans","volume":"75","author":"Lecuyer","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0360","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2013.01.043","article-title":"The skin and hypercoagulable states","volume":"69","author":"Thornsberry","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0365","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaad.2006.11.033","article-title":"Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms","volume":"57","author":"Kriseman","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","author":"Negrini","year":"2017","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0375","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0190-9622(97)80283-6","article-title":"Antiphospholipid syndrome and the skin","volume":"36","author":"Gibson","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.hoc.2007.10.011","article-title":"Cutaneous manifestations of antiphospholipid antibody syndrome","volume":"22","author":"Weinstein","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0385","first-page":"344","article-title":"Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE","volume":"28","author":"Sebastiani","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0390","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0019-5154.108026","article-title":"Update on cutaneous calciphylaxis","volume":"58","author":"Wollina","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0400","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjms.2015.11.015","article-title":"Calciphylaxis: controversies in pathogenesis, diagnosis and treatment","volume":"351","author":"Jeong","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0405","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40257-018-0361-x","article-title":"An update on calciphylaxis","volume":"19","author":"Garcia-Lozano","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0410","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamadermatol.2016.4821","article-title":"Warfarin-associated nonuremic calciphylaxis","volume":"153","author":"Yu","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0420","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.09880912","article-title":"Sodium thiosulfate therapy for calcific uremic arteriolopathy","volume":"8","author":"Nigwekar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0425","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamadermatol.2013.4565","article-title":"Intralesional sodium thiosulfate for the treatment of calciphylaxis","volume":"149","author":"Strazzula","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-017-0653-9","article-title":"Cocaine-levamisole-induced vasculitis\/vasculopathy syndrome","volume":"19","author":"Marquez","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0435","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","article-title":"Characteristic purpura of the ears, vasculitis, and neutropenia\u2014a potential public health epidemic associated with levamisole-adulterated cocaine","volume":"65","author":"Chung","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0440","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13000-015-0279-z","article-title":"Pathologic manifestations of levamisole-adulterated cocaine exposure","volume":"10","author":"Nolan","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0445","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","article-title":"Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?","volume":"63","author":"Waller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0450","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.hoc.2017.08.010","article-title":"Thrombotic microangiopathies (TTP, HUS, HELLP)","volume":"31","author":"Kappler","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0455","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/jth.13764","article-title":"Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics","volume":"15","author":"Saha","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0460","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10067-013-2312-5","article-title":"Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011","volume":"33","author":"Jiang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0465","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/s10165-008-0061-0","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still\u2019s disease: case report and review of the literature","volume":"18","author":"Sayarlioglu","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0470","doi-asserted-by":"crossref","first-page":"953890","DOI":"10.1155\/2011\/953890","article-title":"Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease: a case report","volume":"2011","author":"Souto Filho","year":"2011","journal-title":"Case Rep Med"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0475","article-title":"Thrombotic thrombocytopenic purpura associated with dermatomyositis","volume":"10","author":"Malik","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0480","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0490","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0495","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0500","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.1780330808","article-title":"The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis","volume":"33","author":"Calabrese","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0505","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2019.07.016_bb0510","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/art.1780330809","article-title":"The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura","volume":"33","author":"Mills","year":"1990","journal-title":"Arthritis Rheum"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:10Z","timestamp":1760033770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X19301270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0738081X19301270"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.07.016","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The color of skin: purple diseases of the skin, nails, and mucosa","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}